CARIBOO ROSE RESOURCES LTD (CRB.CA) Fundamental Analysis & Valuation

TSX-V:CRB • CA1420241087

Current stock price

0.06 CAD
0 (0%)
Last:

This CRB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CRB.CA Profitability Analysis

1.1 Basic Checks

  • CRB had negative earnings in the past year.
  • CRB had a negative operating cash flow in the past year.
  • CRB had negative earnings in each of the past 5 years.
  • In the past 5 years CRB always reported negative operating cash flow.
CRB.CA Yearly Net Income VS EBIT VS OCF VS FCFCRB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500K -500K 1M -1M

1.2 Ratios

  • CRB has a Return On Assets (-28.35%) which is comparable to the rest of the industry.
  • CRB has a Return On Equity (-30.65%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -28.35%
ROE -30.65%
ROIC N/A
ROA(3y)-19.17%
ROA(5y)-15.19%
ROE(3y)-21.3%
ROE(5y)-16.8%
ROIC(3y)N/A
ROIC(5y)N/A
CRB.CA Yearly ROA, ROE, ROICCRB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CRB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRB.CA Yearly Profit, Operating, Gross MarginsCRB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CRB.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CRB has more shares outstanding
  • CRB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CRB has an improved debt to assets ratio.
CRB.CA Yearly Shares OutstandingCRB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRB.CA Yearly Total Debt VS Total AssetsCRB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • An Altman-Z score of 15.82 indicates that CRB is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 15.82, CRB is doing good in the industry, outperforming 68.30% of the companies in the same industry.
  • There is no outstanding debt for CRB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.82
ROIC/WACCN/A
WACCN/A
CRB.CA Yearly LT Debt VS Equity VS FCFCRB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1M -1M 2M

2.3 Liquidity

  • A Current Ratio of 1.54 indicates that CRB should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.54, CRB perfoms like the industry average, outperforming 44.78% of the companies in the same industry.
  • CRB has a Quick Ratio of 1.54. This is a normal value and indicates that CRB is financially healthy and should not expect problems in meeting its short term obligations.
  • CRB has a Quick ratio (1.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.54
CRB.CA Yearly Current Assets VS Current LiabilitesCRB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CRB.CA Growth Analysis

3.1 Past

  • The earnings per share for CRB have decreased strongly by -43.64% in the last year.
EPS 1Y (TTM)-43.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CRB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CRB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRB.CA Price Earnings VS Forward Price EarningsCRB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRB.CA Per share dataCRB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRB.CA Dividend Analysis

5.1 Amount

  • No dividends for CRB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRB.CA Fundamentals: All Metrics, Ratios and Statistics

CARIBOO ROSE RESOURCES LTD

TSX-V:CRB (4/14/2026, 7:00:00 PM)

0.06

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.15%
Ins Owner ChangeN/A
Market Cap3.49M
Revenue(TTM)N/A
Net Income(TTM)-444.80K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.4
P/tB 2.4
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -28.35%
ROE -30.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.17%
ROA(5y)-15.19%
ROE(3y)-21.3%
ROE(5y)-16.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 779.59%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.54
Altman-Z 15.82
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)560.01%
Cap/Depr(5y)767.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.32%
OCF growth 3YN/A
OCF growth 5YN/A

CARIBOO ROSE RESOURCES LTD / CRB.CA Fundamental Analysis FAQ

What is the fundamental rating for CRB stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRB.CA.


What is the valuation status of CARIBOO ROSE RESOURCES LTD (CRB.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CARIBOO ROSE RESOURCES LTD (CRB.CA). This can be considered as Overvalued.


Can you provide the profitability details for CARIBOO ROSE RESOURCES LTD?

CARIBOO ROSE RESOURCES LTD (CRB.CA) has a profitability rating of 1 / 10.


How financially healthy is CARIBOO ROSE RESOURCES LTD?

The financial health rating of CARIBOO ROSE RESOURCES LTD (CRB.CA) is 6 / 10.